Arkolith/Insider Trading/NTLA/Form 4

Lebwohl David

EVP, Chief Medical OfficerIntellia Therapeutics, Inc. (NTLA) · full profile →Form 4 · filed Jan 7, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$116K
Net Open-Market Flow
-$116K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2025Sell(S)10K$12.18$116K88K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-003015) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML